Literature DB >> 8936602

ICD-10 field trial of the Diagnostic Criteria for Research in German-speaking countries. Introduction.

H Dilling1, H J Freyberger, R D Stieglitz.   

Abstract

Mesh：

Year:  1996        PMID： 8936602     DOI： 10.1159/000285004

Source DB:  PubMed          Journal:  Psychopathology        ISSN： 0254-4962            Impact factor:   1.944


× No keyword cloud information.
  4 in total

1.  Pilot study on HTR2A promoter polymorphism, -1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive-compulsive disorder.

Authors:  Susanne Walitza; Daniel Sabanés Bové; Marcel Romanos; Tobias Renner; Leonhard Held; Michael Simons; Christoph Wewetzer; Christian Fleischhaker; Helmut Remschmidt; Andreas Warnke; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2011-08-28       Impact factor: 3.575

2.  High resolution chromosomal microarray analysis in paediatric obsessive-compulsive disorder.

Authors:  Edna Grünblatt; Beatrice Oneda; Arif B Ekici; Juliane Ball; Julia Geissler; Steffen Uebe; Marcel Romanos; Anita Rauch; Susanne Walitza
Journal:  BMC Med Genomics       Date:  2017-11-28       Impact factor: 3.063

3.  Association study and a systematic meta-analysis of the VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder.

Authors:  Edna Grünblatt; Anna Maria Werling; Alexander Roth; Marcel Romanos; Susanne Walitza
Journal:  J Neural Transm (Vienna)       Date:  2019-03-28       Impact factor: 3.575

4.  The involvement of the canonical Wnt-signaling receptor LRP5 and LRP6 gene variants with ADHD and sexual dimorphism: Association study and meta-analysis.

Authors:  Edna Grünblatt; Zsofia Nemoda; Anna Maria Werling; Alexander Roth; Nora Angyal; Zsanett Tarnok; Hauke Thomsen; Triinu Peters; Anke Hinney; Johannes Hebebrand; Klaus-Peter Lesch; Marcel Romanos; Susanne Walitza
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-11-25       Impact factor: 3.568
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.